高爾基磷酸化蛋白2(GOLPH2)重組蛋白
Recombinant Golgi Phosphoprotein 2 (GOLPH2)
GOLM1; GP73; C9orf155; Golgi Membrane Protein 1; Golgi Protein 73
- 編號RPB668Hu02
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量45.3kDa
- 實際分子量59kDa(差異分析請參閱說明書)
- 片段與標簽Ser36~Leu401 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 95%
- 等電點4.8
- 應用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1351¥ 3378¥ 6756¥ 20268¥ 50670
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB668Hu01 | 高爾基磷酸化蛋白2(GOLPH2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB668Hu02 | 高爾基磷酸化蛋白2(GOLPH2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB668Hu03 | 高爾基磷酸化蛋白2(GOLPH2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB668Hu04 | 高爾基磷酸化蛋白2(GOLPH2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB668Hu02 | 高爾基磷酸化蛋白2(GOLPH2)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB668Hu01 | 高爾基磷酸化蛋白2(GOLPH2)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB668Hu71 | 高爾基磷酸化蛋白2(GOLPH2)多克隆抗體(生物素標記) | IHC |
| MAB668Hu22 | 高爾基磷酸化蛋白2(GOLPH2)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB668Hu | 高爾基磷酸化蛋白2(GOLPH2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB668Hu | 高爾基磷酸化蛋白2(GOLPH2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Molecular & Cellular Proteomics | LAMC2: A promising new pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues[Mcponline: 023507] |
| Afro-Egypt J Infect Endem Dis | Diagnostic and Prognostic Validity of Serum Golgi Protein 73 in Egyptian Patients with Hepatocelluar Carcinoma[Ajied: Ajied_System_Files] |
| Journal of Applied Pharmaceutical Science | Diagnostic role of Golgi protein 73 and IL-17 in Egyptian cirrhotic rather than hepatocellular carcinoma patients.[handle:123456789] |
| Oncology Letters | Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma[pubmed:29113278] |
| Scientific Reports | The possible role of Dickkopf-1, Golgi protein-73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study[Pubmed: 32198440] |
| Hepatobiliary & Pancreatic Diseases International | Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation[Pubmed: 32171652] |
| Biomolecules | Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-|êB Pathway and Destroying Golgi Structure in Liver Disease. Biomolecules 2021, 11??-[33540642] |
| ADVANCED RESEARCHES | Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C[] |